Brain Neoplasms

Search with Google Search with Bing
Information
Disease name
Brain Neoplasms
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01988675 Completed MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier August 26, 2004 June 3, 2014
NCT00001565 Completed Phase 1 Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy December 1996 October 2000
NCT00001807 Completed (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy April 16, 1999 April 18, 2019
NCT00001502 Completed Phase 1 A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors April 1996 March 2000
NCT06211803 Completed Clinical Application of the Prototype J-PET Device March 11, 2022 March 22, 2022
NCT02105233 Completed Phase 1 Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid February 2014 May 2016
NCT00038441 Completed Phase 1/Phase 2 Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas September 1995 August 2005
NCT05946928 Completed EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY March 1, 2022 December 15, 2022
NCT00054795 Completed Phase 3 Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
NCT00062478 Completed Phase 2 Study of Karenitecin (BNP1350) in Patients With Brain Tumors October 2001
NCT00075166 Completed Phase 4 Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors December 2003 November 2005
NCT00076856 Completed Phase 2 Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) March 31, 2004 March 31, 2006
NCT03910556 Completed Re-craniotomy and Complications After Elective Neurosurgery January 2017 February 2019
NCT00123760 Completed Phase 2/Phase 3 Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer February 2004 December 2008
NCT00128986 Completed Phase 1 Study of Tomotherapy in Patients With Benign Brain Tumour May 2005 August 2014
NCT00138788 Completed Phase 3 Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases February 1996 March 2007
NCT03614403 Completed N/A The Effect of Vitamin D3 on Postoperative Pain in Patients Undergoing Craniotomy July 30, 2017 November 30, 2018
NCT00207298 Completed 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology June 2005 August 2015
NCT00214175 Completed Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy June 2004 January 2011
NCT00233350 Completed Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study January 2007 December 2009
NCT03574467 Completed Functional Outcomes of The Bobath Approach on Patients With Brain Tumors: Comparison With Stroke Patients February 15, 2018 June 12, 2018
NCT00280475 Completed Phase 3 A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis January 2006 January 2013
NCT00297024 Completed Phase 2 Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study) February 2005 May 2013
NCT00312728 Completed Phase 2 A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT) March 2006 June 2009
NCT00314808 Completed Phase 1 A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas April 2006 April 2012
NCT00392119 Completed Phase 1 MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors October 2006 December 2008
NCT00393965 Completed Phase 1 Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases December 2005 February 2008
NCT03525080 Completed N/A Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors June 12, 2018 September 11, 2019
NCT00463203 Completed Phase 2 Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy March 2007 June 2011
NCT03399864 Completed N/A Effectiveness of Musical Training in Hong Kong Chinese Childhood Brain Tumor Survivors February 20, 2017 June 30, 2018
NCT03248544 Completed N/A Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Brain Tumor Surgery July 6, 2017 July 30, 2018
NCT00527657 Completed Phase 1 Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients February 9, 2006 February 2, 2012
NCT02884947 Completed Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI May 2013 December 2016
NCT00649207 Completed Phase 1 A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases March 2008 March 2013
NCT02881957 Completed Phase 2/Phase 3 Hypovitaminosis D in Neurocritical Patients October 10, 2016 October 10, 2018
NCT00681551 Completed Phase 3 Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis February 2003 March 2004
NCT02810899 Completed Phase 4 Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy September 2015 June 2016
NCT02791360 Completed N/A Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor January 2016 December 2017
NCT02754908 Completed N/A Effectiveness of Musical Training in Children Surviving Brain Tumours January 2016 June 30, 2018
NCT00949793 Completed Phase 1 In Vivo Confocal Endomicroscopy of the Brain March 2008 November 2009
NCT02707549 Completed Phase 2 Fluid Therapy During Brain Tumor Resection in Children August 2015 June 2017
NCT00993057 Completed Early Phase 1 Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia October 2009 August 2012
NCT02667587 Completed Phase 3 An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) May 9, 2016 April 9, 2024
NCT01015534 Completed Phase 2 Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment January 2006 October 2009
NCT01017497 Completed N/A Optimal Planning Target Volume With Stereotactic Radiosurgery December 2009 December 2013
NCT01128218 Completed Phase 1/Phase 2 A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors March 2011 February 2021
NCT02603692 Completed Health Related Quality of Life in Pediatric Central Nervous System (CNS) Tumors: A Feasibility Study Utilizing PROMIS November 2014 October 2018
NCT01244737 Completed Phase 2 FLT-PET Imaging of Brain Tumors in Children October 2010 February 5, 2023
NCT02389530 Completed Use of Fluorescein Dye for the Removal of Brain Tumors May 2015 June 2018
NCT01599052 Completed Social Cognition in Children Treated for a Brain Tumour March 2011 March 2017
NCT01642147 Completed N/A Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy November 2012 January 2013
NCT01689402 Completed MRI for the Early Evaluation of Acute Intracerebral Hemorrhage April 2012 May 2017
NCT01793714 Completed Presurgical Language Mapping With fMRI: Comparison of BOLD and fASL Techniques January 21, 2014 December 21, 2017
NCT01931098 Completed Phase 2 Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab December 10, 2015 September 12, 2019
NCT02334722 Completed Phase 4 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients August 5, 2015 October 7, 2020
NCT06001073 Not yet recruiting Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics December 30, 2024 December 31, 2028
NCT06322602 Recruiting N/A Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors February 28, 2024 March 2029
NCT03861299 Recruiting N/A The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. April 1, 2019 September 1, 2027
NCT04111588 Recruiting Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases November 25, 2019 October 1, 2024
NCT04712721 Recruiting Early Phase 1 Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. October 14, 2021 June 26, 2024
NCT04755920 Recruiting Phase 2 SGM-101 in Colorectal Brain Metastases. January 1, 2024 February 2026
NCT04940507 Recruiting N/A BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial June 10, 2021 June 10, 2026
NCT05049148 Recruiting N/A Platelets Activation in Brain Neoplasms October 20, 2022 January 20, 2028
NCT05062772 Recruiting Brain Tumor Intraoperative Ultrasound Database May 25, 2022 December 30, 2023
NCT05084092 Recruiting Phase 2 IORT After Surgical Resection of Brain Metastases June 17, 2020 December 2024
NCT05386108 Recruiting Phase 1/Phase 2 Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer August 31, 2022 December 2025
NCT05538130 Recruiting Phase 1 A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors November 30, 2022 September 28, 2028
NCT05770544 Recruiting Phase 2/Phase 3 DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. June 2024 October 2029
NCT05776602 Recruiting Fast Brain MRI in Children With Suspected Brain Tumor May 1, 2023 December 2025
NCT05776706 Recruiting N/A Clinical Trial for the Validation of AR Based Neuronavigation System June 1, 2023 December 31, 2026
NCT06118723 Recruiting The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) January 1, 2022 January 1, 2028
NCT06128148 Recruiting Phase 1 Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion. May 4, 2022 December 30, 2024
NCT06165653 Recruiting N/A Guided Meditation During Radiation Therapy for Brain Tumors February 29, 2024 January 15, 2028
NCT06273176 Recruiting The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma January 1, 2023 January 1, 2028
NCT06322342 Recruiting Phase 2 Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent March 15, 2024 March 2025
NCT02773888 Suspended N/A An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device December 2015 December 2017
NCT02900248 Terminated CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice October 2, 2017 March 29, 2019
NCT03181581 Terminated Phase 2 Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue. March 1, 2017 December 31, 2018
NCT00659334 Terminated Phase 2 Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation August 2000 March 2010
NCT00479765 Terminated Phase 1/Phase 2 A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma March 2007 October 2009
NCT00234442 Terminated Phase 2 Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer July 2004 February 2006
NCT00034697 Terminated Phase 2 Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) June 28, 2001 January 30, 2003
NCT00121420 Terminated Phase 2 Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
NCT04543188 Terminated Phase 1 A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement January 8, 2021 March 20, 2024
NCT04644315 Terminated Phase 2 A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors May 24, 2021 May 16, 2022
NCT00038389 Terminated Phase 1 Study of Vioxx and Radiation Therapy for Brainstem Glioma October 2001 January 2005
NCT02279992 Terminated Early Phase 1 Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases March 27, 2012 February 11, 2016
NCT01954576 Terminated N/A NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme October 10, 2013 May 14, 2021
NCT01582152 Terminated Phase 1/Phase 2 Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma July 2012 March 2016
NCT02624388 Terminated Phase 2 Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) August 2016 September 2021
NCT02729558 Terminated N/A Local Radiotherapy Following Complete Resection of a Brain Metastasis May 2015 May 2017
NCT00769093 Terminated Phase 1 Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy October 2008 July 2014
NCT00004659 Unknown status Phase 2 Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors November 1994
NCT02007798 Unknown status N/A Small-dose Dexmedetomidine Effects on Recovery Profiles of Supratentorial Tumors Patients From General Anesthesia January 2014 December 2014
NCT02149459 Unknown status Phase 1 Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy June 2014 July 2018
NCT00204295 Unknown status Phase 2 Study on Amino Acid Uptake in Brain Tumors January 2004
NCT03619694 Unknown status Role of MR Spectroscopy in Brain Tumors September 1, 2017 October 1, 2018
NCT00787982 Unknown status Phase 1/Phase 2 Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors September 2008 September 2010
NCT02655536 Unknown status Phase 2 Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial August 1, 2017 December 2019
NCT00040560 Unknown status Phase 1 Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
NCT01012154 Unknown status Phase 1 In Vivo Confocal Microscopy Tumor Atlas Study November 2009 December 2010
NCT00484978 Unknown status Phase 2 Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis February 2007 June 2007
NCT02775136 Unknown status N/A An Evaluation of a Non-invasive Brain Monitor October 2014 December 2017
NCT03462914 Unknown status Comparative Study Between Different Approaches to CPA-petroclival Meningiomas March 15, 2018 May 1, 2019
NCT00457210 Unknown status The Influence of Radiotherapy on Cognitive Function April 2007
NCT00949026 Withdrawn Phase 1 Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis July 2009 May 2010
NCT02307604 Withdrawn SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access May 2016 January 2019
NCT00555984 Withdrawn N/A Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors September 2007 March 2010
NCT02795338 Withdrawn Multi-modality Localization of Eloquent Brain Function March 2017 February 27, 2018
NCT01236586 Withdrawn Phase 1 RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia October 8, 2010 April 13, 2011
NCT00977795 Withdrawn Phase 1/Phase 2 A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors September 2009 January 2010
MeSH unique ID (MeSH (Medical Subject Headings))
D001932